Following the completion of remediation efforts to deal with an FDA warning letter, Chris Phillips, AMRI's senior director of its Burlington, Massachusetts site, discusses what he considers to be a "new bar" in enforcement activity from the agency since 2009.

Published: 02-May-2013

The working year is almost done, time to pause from ‘the business’ and embrace the festive season…go on, give it a big hug. Happy holidays!

Published: 19-Dec-2012

UK CMO Aesica Pharmaceutical says that working with academia to access cutting edge technologies is critical for contractors that want to meet the demands of the modern drug industry.

Published: 06-Dec-2012

Wockhardt sees the ‘fractured CMO space’ as providing opportunities for growth, diversification and greater capacity utilisation.

Published: 14-Jun-2012

Kemwell is set to complete a new biologics manufacturing facility in Bangalore, India, following its long-term partnership with Boehringer Ingelheim.

Published: 29-May-2012

Patheon has launched a new consulting service designed to give emerging biotechs and pharmas a boost in their drug development efforts.

Published: 15-May-2012

Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.

Published: 22-Dec-2011

Quotient has stressed the importance of screening prototype formulations early in the development process to ensure efficient drug delivery in later phases.

Published: 13-Dec-2011

Covance is adding mass spectrometry and other capabilities to meet growing demand for biosimilar comparability services.

Published: 23-Nov-2011

Patheon is considering buying unique drug delivery technologies to expand its development service capabilities.

Published: 14-Nov-2011

Catalent is considering acquisitions as it adds scale, drug delivery technologies and capacity in emerging markets.

Published: 07-Nov-2011

Icon will this year focus its R&D efforts on gaining new grounds in genomics, said Brian O’Dwyer.Icon

Published: 31-Oct-2011

Norwich Pharmaceuticals has expanded its pilot scale production capabilities at its CDMO plant in New York, US.

Published: 27-Oct-2011

Novozymes has achieved a successful supply chain and risk mitigation strategy through implementing its own policy with chemicals company SAFC, says Luke Dimasi.

Published: 26-Sep-2011

SAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week.

Published: 19-Sep-2011

The US FDA has warned that rapid patient enrolment in emerging markets can overload sites that lack the staff to oversee data as it is generated.

Published: 18-Aug-2011

Systemedicus has developed informed consent and patient compliance apps for iPads and iPods and is looking to license the tools to CROs and sponsors.

Published: 08-Aug-2011

The FDA is emphasising the key role both sponsors and CROs play in ensuring high quality clinical trials.

Published: 03-Aug-2011

The Big Pharma CRO strategic partnering model, its impact on drug development and the contract research sector was a hot topic at DIA 2011.

Published: 02-Aug-2011

In June global drug giant Pfizer began what it described as the world’s first ‘virtual trial’ using mobile technology to collect data from patients in their own homes rather than at research sites.

Published: 27-Jul-2011

US CRO Quintiles says that demand for rapid access to clinical trial data is driving the development of vendor neutral management systems.

Published: 13-Jul-2011

Cash-strapped countries are making biopharm consider a product’s fiscal benefits earlier in development, according to INC.

Published: 12-Jul-2011

Parexel says strategic partnerships let pharmaceutical companies streamline how they work with contractors and are changing how CROs view outcomes.

Published: 07-Jul-2011

Synteract says the use of non-validated data systems in clinical trials is a key driver for the ‘rescue study’ segment of the contract research sector.

Published: 06-Jul-2011

Rebranded CRO Theorem Clinical Research talks about life as an independent organisation and the current vogue for private equity investments.

Published: 05-Jul-2011